Abbott is communicating to physicians about a field corrective action related to the HeartMate 3 Left Ventricular Assist Device (LVAD)....
Graft microvasculature is a major target of donor-specific antibodies (DSA) and endothelial damage is a direct evidence of antibody-mediated rejection (ABMR). Using immunohistochemistry, we analyzed the expression...
Vascularized composite allotransplantation (VCA) has emerged as the most recent field of transplantation to offer an alternative treatment for those patients that have failed or are not suitable candidates for conventional therapy.
During faecal microbiota transplantation, stool from a healthy donor is transplanted to treat a variety of dysbiosis-associated gut diseases. Competent authorities are faced with the challenge to provide adequate regulation.
Retina Implant AG's wireless subretinal implant technology, the Alpha IMS, has received CE Mark approval in the EU to treat...
Although peripheral blood stem cells (PBSC) have worldwide become the predominant source of progenitor cells for hematopoietic stem cell transplantation (HSCT), debate about their role compared with bone marrow (BM)...
Boston Scientific Corporation announced it has received FDA approval for the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device.
Medtronic has announced preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Registry, revealing a 99.6 percent implant...
Medtronic plc announced longer-term follow-up results of its investigational EV ICD System, designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.
Novo Nordisk has developed a subcutaneous formulation of semaglutide (OzempicĀ®), a modified human glucagon-like peptide-1 (GLP-1) analogue, for the treatment of type 2 diabetes mellitus.